CDKN1B mutation analyses and biochemical characteristics in patients with symptomatic or asymptomatic primary hyperparathyroidism

Creative Commons License

AKKUŞ G., Coskun N. S. S., Karagun B., TETİKER B. T.

CUKUROVA MEDICAL JOURNAL, cilt.47, sa.2, ss.852-860, 2022 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.17826/cumj.1095425
  • Dergi Adı: CUKUROVA MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Academic Search Premier, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.852-860
  • Anahtar Kelimeler: Primary Hyperparathyroidism, symptomatic hyperparathyroidism, asymptomatic hyperparathyroidism, ENDOCRINE NEOPLASIA TYPE-1, SURGICAL-MANAGEMENT, LOCALIZATION, HYPERCALCEMIA, SCINTIGRAPHY, GUIDELINES, STATEMENT, CALCIUM, SURGERY, GENES
  • Çukurova Üniversitesi Adresli: Evet

Özet

Purpose: The aim of this study was to compare clinical, biochemical and treatment modalities of the patients with symptomatic and asymptomatic PHPT (primary hyperparathyroidism), and evaluate whether the CDKN1B mutation from these patients contributes to the pathogenesis of typical, sporadic parathyroid adenomas.